IO Biotech
Lead Investors
HBM Healthcare Investments AG
대륙
Europe
법인설립년도
2014
산업
Biotechnology
Healthtech
서비스 소개
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
순번
122
지역
Copenhagen
,
Hovedstaden
,
Denmark
최근 투자규모(달러환율 적용)
$127M
최종 투자규모(달러환율적용)
$175M
투자 단계
Post IPO